Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
wakefulness-promoting agent histamine H3 receptor antagonist |
| gptkbp:approvalYear |
2019 (US)
2016 (EU) |
| gptkbp:approvedBy |
gptkb:European_Union
gptkb:United_States |
| gptkbp:ATCCode |
N07XX11
|
| gptkbp:brand |
Wakix
|
| gptkbp:CASNumber |
362665-56-3
|
| gptkbp:developedBy |
Bioprojet
|
| gptkbp:discoveredIn |
gptkb:France
|
| gptkbp:hasMolecularFormula |
C17H26ClNO
|
| https://www.w3.org/2000/01/rdf-schema#label |
pitolisant
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
histamine H3 receptor inverse agonist
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
headache insomnia |
| gptkbp:usedFor |
narcolepsy
|
| gptkbp:bfsParent |
gptkb:H3_receptor
gptkb:histamine_H3_receptor |
| gptkbp:bfsLayer |
7
|